Agency Forms Undergoing Paperwork Reduction Act Review, 25595 [2014-10187]
Download as PDF
<![CDATA[
25595
Federal Register / Vol. 79, No. 86 / Monday, May 5, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30–Day–14–0888]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Persistence of Viable Influenza Virus
in Aerosols (0920–0888, Expiration 05/
31/2014)—Revision—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The National Institute for
Occupational Safety and Health
(NIOSH) is authorized to conduct
research to advance the health and
safety of workers under Section 20(a)(1)
of the 1970 Occupational Safety and
Health Act. Influenza continues to be a
major public health concern because of
the substantial health burden from
seasonal influenza and the potential for
a severe pandemic. Although influenza
is known to be transmitted by infectious
secretions, these secretions can be
transferred from person to person in
many different ways, and the relative
importance of the different pathways is
not known. The likelihood of the
transmission of influenza virus by small
infectious airborne particles produced
during coughing and breathing is
particularly unclear. The question of
airborne transmission is especially
important in healthcare facilities, where
influenza patients tend to congregate
during influenza season, because it
directly impacts the infection control
and personal protective measures that
should be taken by healthcare workers.
The purpose of this study is to
measure the amount of viable influenza
virus in airborne particles that are
produced by patients when they cough,
and the size and quantity of the
particles carrying the virus. A better
understanding of the amount of
potentially infectious material released
by patients and the size of the particles
carrying the virus will assist in
determining the possible role of
airborne transmission in the spread of
influenza and in devising measures to
prevent it.
Volunteer adult participants will be
recruited by a test coordinator using a
poster and flyers describing the study.
Interested potential participants will be
screened verbally to verify that they
have influenza-like symptoms and that
they do not have any medical
conditions that would preclude their
participation.
Qualified participants who agree to
participate in the study will be asked to
read and sign an informed consent form,
and then to complete a short health
questionnaire. After completing the
forms, medical testing will take place.
This testing will include two
nasopharyngeal swabs and one
oropharyngeal swab collected from the
participant. In the final element of
medical testing, they then will be asked
to cough repeatedly into an aerosol
particle collection system, and the
airborne particles produced by the
participant during coughing will be
collected and tested. The sounds
produced during coughing will also be
recorded for analysis and comparison to
the amount of virus expelled. The study
will require 60 volunteer test subjects
each year for 3 years, for a total of 180
test participants. There are no costs to
respondents other than their time. The
total number of annual burden hours
will be 168.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Potential participant
Qualified participant
Qualified participant
Qualified participant
Number of
respondents
Form name
........................................
........................................
........................................
........................................
Initial verbal screening ...................................
Informed consent form ...................................
Health questionnaire ......................................
Medical testing ...............................................
Number of
responses
per
respondent
360
180
180
180
Avgerage
burden per
response
(in hrs.)
1
1
1
1
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
21759–21760). The time and date
should read as follows:
Centers for Disease Control and
Prevention
TIME AND DATE:
[FR Doc. 2014–10187 Filed 5–2–14; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
BILLING CODE 4163–18–P
emcdonald on DSK67QTVN1PROD with NOTICES
3/60
15/60
5/60
30/60
The meeting announced below
concerns Motor Vehicle Injury
Prevention: Evaluation of Increased
Nighttime Enforcement of Seatbelt Use,
Funding Opportunity Announcement
CE14–003, initial review.
SUMMARY: This document corrects a
notice that was published in the Federal
Register on April 17, 2014 (79 FR
VerDate Mar<15>2010
17:56 May 02, 2014
Jkt 232001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
12:00 p.m.–7:00 p.m.,
May 22, 2014 (Closed).
Jane
Suen, Dr.P.H., M.S., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F63, Atlanta, Georgia 30341–
3724, Telephone: (770) 488–4281,
JSuen@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\05MYN1.SGM
05MYN1
]]>Agencies
[Federal Register Volume 79, Number 86 (Monday, May 5, 2014)]
[Notices]
[Page 25595]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10187]
[[Page 25595]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-14-0888]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
Persistence of Viable Influenza Virus in Aerosols (0920-0888,
Expiration 05/31/2014)--Revision--National Institute for Occupational
Safety and Health (NIOSH), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
The National Institute for Occupational Safety and Health (NIOSH)
is authorized to conduct research to advance the health and safety of
workers under Section 20(a)(1) of the 1970 Occupational Safety and
Health Act. Influenza continues to be a major public health concern
because of the substantial health burden from seasonal influenza and
the potential for a severe pandemic. Although influenza is known to be
transmitted by infectious secretions, these secretions can be
transferred from person to person in many different ways, and the
relative importance of the different pathways is not known. The
likelihood of the transmission of influenza virus by small infectious
airborne particles produced during coughing and breathing is
particularly unclear. The question of airborne transmission is
especially important in healthcare facilities, where influenza patients
tend to congregate during influenza season, because it directly impacts
the infection control and personal protective measures that should be
taken by healthcare workers.
The purpose of this study is to measure the amount of viable
influenza virus in airborne particles that are produced by patients
when they cough, and the size and quantity of the particles carrying
the virus. A better understanding of the amount of potentially
infectious material released by patients and the size of the particles
carrying the virus will assist in determining the possible role of
airborne transmission in the spread of influenza and in devising
measures to prevent it.
Volunteer adult participants will be recruited by a test
coordinator using a poster and flyers describing the study. Interested
potential participants will be screened verbally to verify that they
have influenza-like symptoms and that they do not have any medical
conditions that would preclude their participation.
Qualified participants who agree to participate in the study will
be asked to read and sign an informed consent form, and then to
complete a short health questionnaire. After completing the forms,
medical testing will take place. This testing will include two
nasopharyngeal swabs and one oropharyngeal swab collected from the
participant. In the final element of medical testing, they then will be
asked to cough repeatedly into an aerosol particle collection system,
and the airborne particles produced by the participant during coughing
will be collected and tested. The sounds produced during coughing will
also be recorded for analysis and comparison to the amount of virus
expelled. The study will require 60 volunteer test subjects each year
for 3 years, for a total of 180 test participants. There are no costs
to respondents other than their time. The total number of annual burden
hours will be 168.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Avgerage
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Potential participant............ Initial verbal screening..... 360 1 3/60
Qualified participant............ Informed consent form........ 180 1 15/60
Qualified participant............ Health questionnaire......... 180 1 5/60
Qualified participant............ Medical testing.............. 180 1 30/60
----------------------------------------------------------------------------------------------------------------
Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-10187 Filed 5-2-14; 8:45 am]
BILLING CODE 4163-18-P
